Wide Ranks

EVOK

Evoke Pharma, Inc.

4.37

Top Statistics
Market Cap 6 M Forward PE 9.10 Revenue Growth 69.80 %
Current Ratio 1.44 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -71.33 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA Enterprise / Revenue 0.0180 Price To Sales Trailing12 Months 0.7536
Profitability
Profit Margins -71.33 % Operating Margins -48.44 %
Balance Sheet
Total Cash 11 M Total Cash Per Share 7.63 Total Debt 5 M
Total Debt To Equity 113.97 Current Ratio 1.44 Book Value Per Share 4.90
All Measures
Short Ratio 2.00 % Message Board Id finmb_35230943 Shares Short Prior Month 25992
Return On Equity -3.50 City Solana Beach Uuid abcf0009-3a96-3d48-8e1a-293b075f6af2
Previous Close 4.37 First Trade Date Epoch Utc 1 B Book Value 4.90
Beta 0.3480 Total Debt 5 M Volume 13191
Price To Book 0.8913 Last Split Date 1 B Fifty Two Week Low 3.54
Total Cash Per Share 7.63 Total Revenue 8 M Shares Short Previous Month Date 1 B
Target Median Price 18.00 Max Age 86400 Sand P52 Week Change 0.3133
Operating Margins -48.44 % Target Mean Price 18.00 Net Income To Common -6146829
Short Percent Of Float 0.0115 Implied Shares Outstanding 1 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 39600 Average Volume10days 39600
Total Cash 11 M Next Fiscal Year End 1 B Revenue Per Share 7.79
Held Percent Insiders 0.0459 Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 4.37 Target Low Price 18.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 5.15 Open 4.35
Free Cashflow -1490945 State CA Dividend Yield 0.00 %
Return On Assets -0.3350 Time Zone Short Name EST Trailing Eps -10.13
Day Low 4.31 Address1 420 Stevens Avenue Shares Outstanding 1 M
Price Hint 4 Target High Price 18.00 Website https://www.evokepharma.com
52 Week Change -0.7194 Average Volume 385226 Forward Eps 0.4800
Recommendation Key none Compensation As Of Epoch Date 1 B Quick Ratio 136.80 %
Last Split Factor 1:12 Regular Market Day High 4.42 Is_sp_500 False
Profit Margins -71.33 % Debt To Equity 113.97 Fifty Two Week High 17.40
Day High 4.42 Shares Short 16990 Regular Market Open 4.35
Industry Key drug-manufacturers-specialty-generic Earnings Growth 0.00 % Enterprise To Revenue 0.0180
Revenue Growth 69.80 % Shares Percent Shares Out 0.0114 Operating Cashflow -5324804
Currency USD Time Zone Full Name America/New_York Market Cap 6 M
Is_nasdaq_100 False Zip 92075 Quote Type EQUITY
Industry Drug Manufacturers - Specialty & Generic Long Name Evoke Pharma, Inc. Regular Market Day Low 4.31
Held Percent Institutions 0.1713 Current Price 4.37 Address2 Suite 230
Financial Currency USD Current Ratio 1.44 Gross Margins 96.55 %
Industry Disp Drug Manufacturers - Specialty & Generic Number Of Analyst Opinions 1 Country United States
Float Shares 969457 Two Hundred Day Average 5.88 Enterprise Value 154827
Price To Sales Trailing12 Months 0.7536 Forward PE 9.10 Regular Market Volume 13191
Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases.

It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults.

The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers.

Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.